Cempra, Inc. (CEMP)

[Johnny_C]

CEMP made a very big mistake deciding to take this to market without a major partner.

1. On top of the dilution, they are now paying salespeople to sit around.

2. By not partnering with a major brand salespeople will only have one product to trot in to show doctors.

3. If there is a major issue with the distributor in India the FDA could shut this down until CEMP gets a distribution partner that meets FDA standards. If the active ingredient is not exactly the same all the previous trials, no matter how good they are and no matter the need for this anti biotic, could be shelved and new trials may be needed.


The risk here was very much in the open. I was vocal against all the dilution. The banks had a terrible year with underwritings and they sold CEMP lock stock and barrel on this dilution. It does not matter if the FDA loves the drug if there are issues with the active ingredient at the source.

Have made good trades here 3 times so CEMP doesn't owe us anything, but if they were offered in the 40's earlier in the year by a major partner they should have taken it.

Hope they figure this out quickly. It is bizarre that articles are being written about these issues without a press release. This is a material event if true